Podcasts

AUDIO: Conjugated estrogen, bazedoxifene combo offers menopause treatment option


 

EXPERT ANALYSIS FROM THE NAMS ANNUAL MEETING

References

NATIONAL HARBOR, MD. – Treating menopause symptoms in women who still have a uterus can be difficult, but alternatives to estrogen are available.

For many women, the use of estrogen therapies is contraindicated – and even if it is prescribed, many women are noncompliant because of fears of increased risk of breast or uterine cancer, explained Dr. JoAnn Pinkerton of the University of Virginia, Charlottesville.

However, with the U.S. Food and Drug Administration’s recent approval of Duavee, a combination of conjugated estrogen and bazedoxifene, Dr. Pinkerton noted, women who don’t want to take estrogen have another option for quelling their menopause symptoms.

In an interview at the annual meeting of the North American Menopause Society, Dr. Pinkerton analyzes the benefits of combination therapy.

wmcknight@frontlinemedcom.com

On Twitter @whitneymcknight

Recommended Reading

Variants of hypogonadism in aging men warrant different treatments
MDedge Internal Medicine
Should LCZ696 receive a level I indication?
MDedge Internal Medicine
Eating fried food before pregnancy may increase risk of gestational diabetes
MDedge Internal Medicine
GLINT to test metformin’s effect on cardiovascular outcomes
MDedge Internal Medicine
Retinopathy screening during gestational diabetes may be lacking
MDedge Internal Medicine
Insulin degludec effectively intensifies type 2 diabetes treatment
MDedge Internal Medicine
Diabetes-related increased cancer risk may be statistical artifact
MDedge Internal Medicine
Embryonic stem cells improved vision in macular degeneration
MDedge Internal Medicine
Insulin pumps associated with reduced risk of cardiovascular disease
MDedge Internal Medicine
VIDEO: Is the FDA’s black box on estrogen too ‘alarming’?
MDedge Internal Medicine